TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dancing for Better Aging: Evaluating the Impact of a Dance/Movement Therapy Program for Older Adults Through an Empirical Research Approach
Brief Summary: The aim of this study is to empirically evaluate the impact of a Dance/Movement Therapy program adapted to older adults. Participants over 60 years old are enrolled in one of three groups: Dance/Movement Therapy, Aerobic Exercise or Waiting List (control group) for 12 weeks. The training groups occur 3 times a week for 1 hour each session. Physical condition, cognitive function, general health and lifestyle, and stress hormones are assessed at baseline, after 12 weeks and after 28 weeks.


Options:
A: Arm Label: SeRenade Program; Type: EXPERIMENTAL; Interventions: Behavioral: SeRenade Parent-Child Music Class | Arm Label: Delayed/Waitlist Program; Type: EXPERIMENTAL; Interventions: Behavioral: Delayed Intervention | Intervention Type: BEHAVIORAL; Name: SeRenade Parent-Child Music Class; Assigned to Arm(s): SeRenade Program | Intervention Type: BEHAVIORAL; Name: Delayed Intervention; Assigned to Arm(s): Delayed/Waitlist Program
B: Arm Label: Study; Type: EXPERIMENTAL; Interventions: Behavioral: music therapy sessions . | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: music therapy sessions .; Assigned to Arm(s): Study
C: Arm Label: Dance/Movement Therapy (DMT); Type: EXPERIMENTAL; Interventions: Other: Dance/Movement Therapy (DMT) | Arm Label: Aerobics Exercise (AE); Type: ACTIVE_COMPARATOR; Interventions: Other: Aerobics Exercise (AE) | Arm Label: Waiting List; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Dance/Movement Therapy (DMT); Assigned to Arm(s): Dance/Movement Therapy (DMT) | Intervention Type: OTHER; Name: Aerobics Exercise (AE); Assigned to Arm(s): Aerobics Exercise (AE)
D: Arm Label: Music therapy; Type: EXPERIMENTAL; Interventions: Other: Music therapy | Arm Label: Behavioral-based social skill training; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral-based social skill training | Intervention Type: OTHER; Name: Music therapy; Assigned to Arm(s): Music therapy | Intervention Type: BEHAVIORAL; Name: Behavioral-based social skill training; Assigned to Arm(s): Behavioral-based social skill training

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety of Transcranial Direct Current Stimulation in the Subacute Phase After Stroke
Brief Summary: Stroke is the second cause of death worldwide and represented the first cause of death in Brazil between 2006 and 2010. Most patients survive, and there is a need to develop cost-effective rehabilitation strategies to decrease the burden of disability from stroke.

This study addresses this important issue, by evaluating, in the early phase post-stroke, effects of motor conventional physical therapy associated or not with transcranial direct current stimulation (tDCS).


Options:
A: Arm Label: Real; Type: ACTIVE_COMPARATOR; Interventions: Device: transcranial direct current stimulation tDCS, Device: transcranial magnetic stimulation TMS | Arm Label: sham; Type: PLACEBO_COMPARATOR; Interventions: Device: transcranial direct current stimulation tDCS, Device: transcranial magnetic stimulation TMS | Intervention Type: DEVICE; Name: transcranial direct current stimulation tDCS; Assigned to Arm(s): Real, sham | Intervention Type: DEVICE; Name: transcranial magnetic stimulation TMS; Assigned to Arm(s): Real, sham
B: Arm Label: subcortical; Type: EXPERIMENTAL; Interventions: Device: tDCS | Arm Label: cortical; Type: EXPERIMENTAL; Interventions: Device: tDCS | Intervention Type: DEVICE; Name: tDCS; Assigned to Arm(s): cortical, subcortical
C: Arm Label: Active tDCS+ Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Active tDCS, Other: Physical Therapy | Arm Label: Sham tDCS+Physical Therapy; Type: SHAM_COMPARATOR; Interventions: Other: Physical Therapy, Device: Sham tDCS | Intervention Type: DEVICE; Name: Active tDCS; Assigned to Arm(s): Active tDCS+ Physical Therapy | Intervention Type: OTHER; Name: Physical Therapy; Assigned to Arm(s): Active tDCS+ Physical Therapy, Sham tDCS+Physical Therapy | Intervention Type: DEVICE; Name: Sham tDCS; Assigned to Arm(s): Sham tDCS+Physical Therapy
D: Intervention Type: DEVICE; Name: combined transcranial direct current stimulation and electrical peripheral nerve stimulation; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Esmolol Reduces Anesthetic Requirements Thereby Facilitating Early Extubation; a Prospective Controlled Study in Patients Undergoing Intracranial Surgery
Brief Summary: Anesthesia techniques that minimize anesthetic requirements and their effects may be beneficial. Esmolol, a short acting hyperselective β-adrenergic blocker is effective in blunting adrenergic response to several perioperative stimuli and so it might interfere in the effect of the anesthetic drugs on the brain. This study was designed to investigate the effect of esmolol on the consumption of propofol and sevoflurane in patients undergoing craniotomy.


Options:
A: Arm Label: Esmolol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Esmolol, Drug: Propofol and sevoflurane | Arm Label: control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Esmolol; Assigned to Arm(s): Esmolol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): control | Intervention Type: DRUG; Name: Propofol and sevoflurane; Assigned to Arm(s): Esmolol
B: Arm Label: Midazolam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam | Arm Label: Propofol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): Propofol | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Midazolam
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2
D: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Efficacy of 4 Oral Analgesics for the Initial Management of Acute Musculoskeletal Extremity Pain
Brief Summary: The purpose of this study is to perform a randomized, double blind 4-arm clinical trial of the comparative efficacy of 4 oral analgesics in the initial management of acute musculoskeletal extremity pain presenting to the ED.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol, Drug: Ibuprofen placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Ibuprofen, Drug: Paracetamol Placebo | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol, Drug: Ibuprofen | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): 2, 3 | Intervention Type: DRUG; Name: Paracetamol Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Ibuprofen placebo; Assigned to Arm(s): 1
B: Arm Label: oral morphine and oral ibuprofen; Type: EXPERIMENTAL; Interventions: Drug: oral morphine and oral ibuprofen | Arm Label: morphine and placebo of ibuprofen; Type: EXPERIMENTAL; Interventions: Drug: Oral morphine | Arm Label: ibuprofen and placebo of morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral ibuprofen | Intervention Type: DRUG; Name: oral morphine and oral ibuprofen; Assigned to Arm(s): oral morphine and oral ibuprofen | Intervention Type: DRUG; Name: Oral morphine; Assigned to Arm(s): morphine and placebo of ibuprofen | Intervention Type: DRUG; Name: Oral ibuprofen; Assigned to Arm(s): ibuprofen and placebo of morphine
C: Arm Label: Oxycodone/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone/acetaminophen | Arm Label: Hydrocodone/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydrocodone/acetaminophen | Arm Label: Codeine/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Codeine/acetaminophen | Arm Label: Ibuprofen/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ibuprofen/acetaminophen | Intervention Type: DRUG; Name: Oxycodone/acetaminophen; Assigned to Arm(s): Oxycodone/acetaminophen | Intervention Type: DRUG; Name: Hydrocodone/acetaminophen; Assigned to Arm(s): Hydrocodone/acetaminophen | Intervention Type: DRUG; Name: Codeine/acetaminophen; Assigned to Arm(s): Codeine/acetaminophen | Intervention Type: DRUG; Name: Ibuprofen/acetaminophen; Assigned to Arm(s): Ibuprofen/acetaminophen
D: Arm Label: Paracetamol; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol | Arm Label: Dexketoprofen; Type: EXPERIMENTAL; Interventions: Drug: Dexketoprofen | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol | Intervention Type: DRUG; Name: Dexketoprofen; Assigned to Arm(s): Dexketoprofen

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of a Pedometer Based Phased Intervention to Encourage Physical Activity in Schools: A Feasibility Study.
Brief Summary: A school based pedometer competition among Year 9 pupils (12 - 14 years old) to promote physical activity (PA).


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The StepSmart Challenge | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The StepSmart Challenge; Assigned to Arm(s): Intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Teacher-Delivered Weight Control Intervention | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Teacher-Delivered General Health Intervention | Intervention Type: BEHAVIORAL; Name: Teacher-Delivered Weight Control Intervention; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Teacher-Delivered General Health Intervention; Assigned to Arm(s): 2
C: Arm Label: Usual Practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Action Schools! BC; Type: EXPERIMENTAL; Interventions: Behavioral: Action Schools! BC | Intervention Type: BEHAVIORAL; Name: Action Schools! BC; Assigned to Arm(s): Action Schools! BC
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: 6 months of healthy physical activity | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: 6 months of healthy physical activity; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Strengthening Physician Communication About HPV Vaccines
Brief Summary: The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric and family medicine practices.


Options:
A: Arm Label: Education about HPV by school nurse; Type: EXPERIMENTAL; Interventions: Behavioral: Education about HPV by school nurse | Arm Label: Control group 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education about HPV by school nurse; Assigned to Arm(s): Education about HPV by school nurse
B: Arm Label: Class-based delivery; Type: OTHER; Interventions: Biological: Gardasil® HPV vaccine | Arm Label: Age-based delivery; Type: OTHER; Interventions: Biological: Gardasil® HPV vaccine | Intervention Type: BIOLOGICAL; Name: Gardasil® HPV vaccine; Assigned to Arm(s): Age-based delivery, Class-based delivery
C: Arm Label: Intervention Practices; Type: EXPERIMENTAL; Interventions: Behavioral: Multimodal Vaccine Program | Arm Label: Control Practices; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Multimodal Vaccine Program; Assigned to Arm(s): Intervention Practices
D: Arm Label: Outreach; Type: OTHER; Interventions: Other: outreach services | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: outreach services; Assigned to Arm(s): Outreach

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Xenogenous Collagen Matrix Graft Associated or Not With Enamel Matrix Derivative Proteins in the Treatment of Gingival Recession Class I and II of Miller: Randomized Controlled Clinical Study
Brief Summary: The purpose of this study is to evaluate the reduction of gingival recession of single Miller Class I and II defects treated by coronally advanced flap with subepithelial porcine collagen matrix graft and / or enamel matrix proteins.


Options:
A: Arm Label: CAF+MC+EMD; Type: EXPERIMENTAL; Interventions: Device: Mucograft, Device: Emdogain, Procedure: Coronally Advanced flap | Arm Label: CAF+MC; Type: ACTIVE_COMPARATOR; Interventions: Device: Mucograft, Procedure: Coronally Advanced flap | Arm Label: CAF+EMD; Type: ACTIVE_COMPARATOR; Interventions: Device: Emdogain, Procedure: Coronally Advanced flap | Arm Label: CAF; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Coronally Advanced flap | Intervention Type: DEVICE; Name: Mucograft; Assigned to Arm(s): CAF+MC, CAF+MC+EMD | Intervention Type: DEVICE; Name: Emdogain; Assigned to Arm(s): CAF+EMD, CAF+MC+EMD | Intervention Type: PROCEDURE; Name: Coronally Advanced flap; Assigned to Arm(s): CAF, CAF+EMD, CAF+MC, CAF+MC+EMD
B: Arm Label: CAF plus connective tissue graft; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CAF plus connective tissue graft, Drug: Sodium dipyrone, Drug: chlorhexidine rinse | Arm Label: Tunnel plus connective tissue graft; Type: EXPERIMENTAL; Interventions: Procedure: Tunnel plus connective tissue graft, Drug: Sodium dipyrone, Drug: chlorhexidine rinse | Intervention Type: PROCEDURE; Name: CAF plus connective tissue graft; Assigned to Arm(s): CAF plus connective tissue graft | Intervention Type: PROCEDURE; Name: Tunnel plus connective tissue graft; Assigned to Arm(s): Tunnel plus connective tissue graft | Intervention Type: DRUG; Name: Sodium dipyrone; Assigned to Arm(s): CAF plus connective tissue graft, Tunnel plus connective tissue graft | Intervention Type: DRUG; Name: chlorhexidine rinse; Assigned to Arm(s): CAF plus connective tissue graft, Tunnel plus connective tissue graft
C: Arm Label: test and control; Type: EXPERIMENTAL; Interventions: Procedure: Periodontal surgery to gingival recessions | Intervention Type: PROCEDURE; Name: Periodontal surgery to gingival recessions; Assigned to Arm(s): test and control
D: Arm Label: Mucograft + CAF; Type: EXPERIMENTAL; Interventions: Device: Mucograft | Arm Label: CAF; Type: EXPERIMENTAL; Interventions: Procedure: Coronally advanced flap (CAF) | Intervention Type: DEVICE; Name: Mucograft; Assigned to Arm(s): Mucograft + CAF | Intervention Type: PROCEDURE; Name: Coronally advanced flap (CAF); Assigned to Arm(s): CAF

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention
Brief Summary: The primary objective of the study was to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days.


Options:
A: Arm Label: botulinum toxin Type A; Type: EXPERIMENTAL; Interventions: Biological: Botulinum Toxin Type A | Arm Label: Placebo (saline); Type: PLACEBO_COMPARATOR; Interventions: Other: placebo (saline) | Intervention Type: BIOLOGICAL; Name: Botulinum Toxin Type A; Assigned to Arm(s): botulinum toxin Type A | Intervention Type: OTHER; Name: placebo (saline); Assigned to Arm(s): Placebo (saline)
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Fremanezumab 675 mg/placebo/placebo; Type: EXPERIMENTAL; Interventions: Drug: Fremanezumab, Drug: Placebo | Arm Label: Fremanezumab 675/225/225 mg; Type: EXPERIMENTAL; Interventions: Drug: Fremanezumab | Intervention Type: DRUG; Name: Fremanezumab; Assigned to Arm(s): Fremanezumab 675 mg/placebo/placebo, Fremanezumab 675/225/225 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Fremanezumab 675 mg/placebo/placebo, Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Erenumab 70 mg QM; Type: EXPERIMENTAL; Interventions: Drug: Erenumab | Arm Label: Erenumab 140 mg QM; Type: EXPERIMENTAL; Interventions: Drug: Erenumab | Intervention Type: DRUG; Name: Erenumab; Assigned to Arm(s): Erenumab 140 mg QM, Erenumab 70 mg QM | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: botulinum toxin Type A; Type: EXPERIMENTAL; Interventions: Biological: Botulinum Toxin Type A | Arm Label: Placebo (saline); Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo (saline) | Intervention Type: BIOLOGICAL; Name: Botulinum Toxin Type A; Assigned to Arm(s): botulinum toxin Type A | Intervention Type: OTHER; Name: Placebo (saline); Assigned to Arm(s): Placebo (saline)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome
Brief Summary: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a poorly understood disease with unreliable treatments. Although it is not known what causes it for certain, we do know that life stressors may make the disease worse or cause flares. Mindfulness Based Stress Reduction (MBSR) is an 8 week class focused on meditation and other techniques that the investigators think may be helpful to people with IC/BPS. This trial will assign participants to an MBSR class or usual care for their IC/BPS to see if the MBSR class would be helpful for their disease.


Options:
A: Arm Label: Global Therapeutic Massage (GTM); Type: SHAM_COMPARATOR; Interventions: Other: Global Therapeutic Massages (GTM) | Arm Label: Myofascial Tissue Manipulation (MTM); Type: ACTIVE_COMPARATOR; Interventions: Other: Myofascial Tissue Manipulation (MTM) | Intervention Type: OTHER; Name: Global Therapeutic Massages (GTM); Assigned to Arm(s): Global Therapeutic Massage (GTM) | Intervention Type: OTHER; Name: Myofascial Tissue Manipulation (MTM); Assigned to Arm(s): Myofascial Tissue Manipulation (MTM)
B: Arm Label: Pentosan polysulfate sodium 100 mg once a day; Type: EXPERIMENTAL; Interventions: Drug: Pentosan polysulfate sodium 100 mg | Arm Label: Pentosan polysulfate sodium 100 mg three times a day; Type: EXPERIMENTAL; Interventions: Drug: Pentosan polysulfate sodium 100 mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Pentosan polysulfate sodium 100 mg; Assigned to Arm(s): Pentosan polysulfate sodium 100 mg three times a day | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Pentosan polysulfate sodium 100 mg; Assigned to Arm(s): Pentosan polysulfate sodium 100 mg once a day
C: Arm Label: Mindfulness-based Stress Reduction; Type: EXPERIMENTAL; Interventions: Other: Mindfulness-based Stress Reduction (MBSR), Other: Usual medical therapy | Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual medical therapy | Intervention Type: OTHER; Name: Mindfulness-based Stress Reduction (MBSR); Assigned to Arm(s): Mindfulness-based Stress Reduction | Intervention Type: OTHER; Name: Usual medical therapy; Assigned to Arm(s): Mindfulness-based Stress Reduction, Usual Care
D: Arm Label: Life-Stress Interview; Type: EXPERIMENTAL; Interventions: Behavioral: Life-Stress Interview | Arm Label: Wait-list Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Life-Stress Interview; Assigned to Arm(s): Life-Stress Interview

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos in Primary Care (E-LITE Latinos)
Brief Summary: The purpose of the study is to develop a culturally adapted intervention (CAI) program to improve weight and physical activity in overweight or obese adult Latinos at high risk for developing type 2 diabetes and/or cardiovascular disease (CVD) and to rigorously evaluate the effectiveness and implementation potential of the CAI program.


Options:
A: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Structured Education | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written Information | Intervention Type: BEHAVIORAL; Name: Structured Education; Assigned to Arm(s): Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Written Information; Assigned to Arm(s): Control
B: Arm Label: 1 Original Lifestyle; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Behavioral: DPPOS Boost Lifestyle, Behavioral: Intensive Lifestyle Group Session | Arm Label: 2 Original Metformin; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Drug: Metformin, Behavioral: Intensive Lifestyle Group Session | Arm Label: 3 Original Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Behavioral: Intensive Lifestyle Group Session | Intervention Type: BEHAVIORAL; Name: DPPOS Group Lifestyle; Assigned to Arm(s): 1 Original Lifestyle, 2 Original Metformin, 3 Original Placebo | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 2 Original Metformin | Intervention Type: BEHAVIORAL; Name: DPPOS Boost Lifestyle; Assigned to Arm(s): 1 Original Lifestyle | Intervention Type: BEHAVIORAL; Name: Intensive Lifestyle Group Session; Assigned to Arm(s): 1 Original Lifestyle, 2 Original Metformin, 3 Original Placebo
C: Arm Label: Lifestyle; Type: EXPERIMENTAL; Interventions: Behavioral: Group-Based Lifestyle Intervention (Phases 1 and 2), Behavioral: Self-Directed Maintenance (Phase 3), Behavioral: Extended Group Maintenance (Phase 3) | Arm Label: Comparison; Type: OTHER; Interventions: Other: Individual Education Program (All Phases) | Intervention Type: BEHAVIORAL; Name: Group-Based Lifestyle Intervention (Phases 1 and 2); Assigned to Arm(s): Lifestyle | Intervention Type: OTHER; Name: Individual Education Program (All Phases); Assigned to Arm(s): Comparison | Intervention Type: BEHAVIORAL; Name: Self-Directed Maintenance (Phase 3); Assigned to Arm(s): Lifestyle | Intervention Type: BEHAVIORAL; Name: Extended Group Maintenance (Phase 3); Assigned to Arm(s): Lifestyle
D: Arm Label: Usual Care Only; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Only | Arm Label: Vida Sana; Type: EXPERIMENTAL; Interventions: Behavioral: Vida Sana | Intervention Type: BEHAVIORAL; Name: Vida Sana; Assigned to Arm(s): Vida Sana | Intervention Type: OTHER; Name: Usual Care Only; Assigned to Arm(s): Usual Care Only

Answer: D